ArticleNature genetics2015

In situ single-cell analysis identifies heterogeneity for PIK3CA mutation and HER2 amplification in HER2-positive breast cancer.

Michalina Janiszewska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.